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Abstract—Vector-borne diseases such as malaria, lymphatic filariases, schistosomiasis, leishmaniasis,
onchocerciasis, trypanosomiasis, dengue and dengue haemorrhagic fever (DHF), yellow fever and
Japanese encephalitis, globally account for suffering amongst more than one billion people, mostly from
the developing world. Geographical distribution and prevalence of these diseases have been discussed. In
addition to the mortality caused by these diseases, millions of people lead a hopeless life and are socially
unable to achieve self-realization and be economically productive, as a result of these diseases. Examples
of such economic impact and the costs of these diseases and methods of control have been given. Economic
benefits of control of some of these diseases have been discussed. These concepts are of utility when
resource allocation for control of these diseases is under consideration.
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Resume—Les maladies transmises par des vecteurs telles que le paludisme, la filariose lymphatique, la
schistosomiase, la leishmaniose, l'onchocercose, la trypanosomiase, la dengue et la dengue hemorragique,
la fievre jaune et l'encephalite japonaise affectent au total plus d'un milliard de personnes dans le monde,
principalement dans les pays en developpement. La question de la repartition geographique et de la
prevalence de ces maladies a ete examinee. Outre qu'elles sont des causes importantes de mortalite, elles
sont directement responsables du fait que des millions de personnes menent une vie sans espoir et sont
socialement incapables de s'assumer et d'etre economiquement productives. Des exemples de l'impact
economique et du cout de ses maladies et des methodes de lutte pertinentes ont ete fournis. Les avantages
economiques decoulant de la maitrise de certaines de ces maladies ont aussi ete passes en revue. Ces
concepts sont utiles lorsqu'on examine l'allocation des ressources pour la lutte contre ces maladies.
MAGNITUDE OF THE PROBLEM
Vector-borne* diseases globally account for suffering
amongst more than one billion people, the majority
of whom belong to the developing countries. These
same countries also are the scene of other socio-
economic and developmental phenomena, some of
which adversely affect health. Natural disasters, such
as drought, and man-made political crises, such as the
threat of war, problem of refugees, compounded with
growth of population, growing urbanization and
other trends have created significant socio-economic
disparities in vast areas of the developing world.
Absolute poverty, traps almost 1000 m people.
This is reflected in the life expectancy at birth
(significantly lower in the developing countries, as
compared to the developed countries) and infant
mortality rates (50-100 or more per 1000 live births
in many developing countries, and below 50 in most
of the developed countries). Infectious and parasitic
diseases (which include the vector-borne diseases)
cause 40% of the total deaths in the developing
countries, compared to 8% in the developed coun-
*The term vector has been used in a broad sense and
includes primary and intermediate vertebrate and in-
vertebrate hosts and animal reservoirs of human dis-
eases.
tries. Major vector-borne diseases are malaria, lym-
phatic filariases, schistosomiasis, leishmaniasis, on-
chocerciasis, trypanosomiasis (both African and
American), dengue and dengue haemorrhagic fever
(DHF), yellow fever and Japanese encephalitis. In
addition, plague continues to persist in scattered foci
in many countries, as well as louse-borne relapsing
fever, tick-borne rickettsiosis, typhus and viral hae-
morrhagic fevers constituting important health prob-
lems locally. Leptotrombidium and other mites called
"chiggers" are also important in some areas of the
world.
Table 1 shows the recent status of different vector-
borne diseases globally and Figs 1-9 present their
distribution. In addition to the data presented on
seven vector/reservoir-borne diseases, dengue/DHF
is reported to have caused hospitalization of about
750,000 people and 20,000 deaths during the past 25
years in only a few countries of South Asia; and
Japanese encephalitis has caused high case fatality
rates during outbreaks.
Dracunculiasis disease transmitted by ingestion of
infected cyclops is widely distributed in the Western
part of India and in about 17 countries of Africa.
In addition to the diseases that they transmit, many
arthropods contribute to human misery through
sheer numbers, annoyance, allergies and discomfort
which they cause. Flies, bed-bugs, cerapatogonidae
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Table 1. Estimated global status of vector-borne diseases (Global population estimated at 4.75 billion)
Disease
Population
at risk
(millions)
No. of clinical
cases
(thousands)
Areas specifically
affected Remarks
Malaria
Lymphatic filariases
Schistosomiasis
Onchocerciasis
African trypanosomiasis
Chagas' disease
Leishmaniases
Dracunculiasis
2,209
905
600
85
50
65
No estimates
available
63
97,978
90,200
200,000
17,000
(No. of blind people
estimated at 336,000)
(20,000 new cases/year)
10,000 to 20,000
50
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Figs 7 and
Fig. 9
Major public health problem
globally. Imr >rtant cause
of child re jrtality in Africa
Acute cases cause much
suffering, although not a
killing disease
Chronic debilitating disease
closely related to water
development projects
Disease results in blindness
and causes severe socio-
economic problems
Endemic in 36 countries of
Africa, south of Sahara
Disease exclusive to Americas.
Disease associated with poverty
Disease exclusive to W India,
Pakistan and Central and
Western parts of Africa
and cockroaches are some of the examples, and large
amounts of money are spent on controlling these
pests. Urban pest problems are another aspect of the
importance of vectors and vector control. In a survey
carried out by WHO, it was estimated that in 1980
roughly $800 m were spent on urban vector control.
In north-eastern United States of America alone,
roughly $400 million are spent on cockroach control.
With the rapidly developing air and sea trans-
portation services, and the epidemiological problems
related to the transportation of vectors, disinfection
of aircraft and vessels is assuming more importance.
Status of vector control
The above is rather a grim situation and now we
will briefly review what is actually being done glob-
ally as far as control of vectors of the above diseases
are concerned. Control of malaria vectors is still
primarily carried out using chemical insecticides as
residual sprays. DDT is still used to a large extent in
rural areas where the vector(s) is susceptible because
of comparatively low cost and safety record to man
when used indoors. With the onset of resistance,
organophosphate (OP) compounds, such as mal-
athion, fenitrothion, pirimiphosmethyl and car-
bamates, such as propoxur and bendiocarb, are used.
Other insecticides, which have given satisfactory re-
sults are chlorphoxim and pyrethroids such as perme-
thrin and deltamethrin. However, some of these
compounds have still been used only experimentally.
Larvicides, such as temephos, and larvicidal oils for
the control of exophilic/endophilic mosquitoes where
the larval habitats are restricted and readily acces-
sible, such as urban or periurban areas, sometimes in
conjunction with ULV applications, as supple-
mentary measures, have also been employed. Bacte-
rial pathogens have been tried but not used on an
extensive scale, e.g., B.t. H-14, one exception being
the Onchocerciasis Control Programme in West
Africa where B.t. H-14 is used operationally. Much
attention is now being given to the use of fish. For
example, larvivorous fish, Gambusia affinis and
Poecilia reticulata are being used on a relatively large
scale for the control of Anopheles stephensi in urban
areas of India. Environmental measures, such as
source reduction, sanitation and water management,
are presently limited to very few areas as a malaria
vector control measure.
An effective drug is available for filariasis control
(Diethyl carbamazine) and this approach, within the
context of primary health care, is currently being used
in several countries, but appropriate vector control
methodology, such as source reduction, source
modification, drainage, canalization of marshes and
swamps, use of larvivorous fish, afforestation to-
gether with the use of chemical larvicides, such as
fenthion or chlorpyrifos in polluted waters, have been
used in some programmes. Herbicides have been used
for controlling host plants of Mansonia and use of
temephos for reducing populations of Aedes poly-
nesiensis is being made. For filariasis control, vector
control through community participation has been
demonstrated as a successful approach in limited
urban areas.
The primary urban vector of dengue and DHF,
and other diseases like yellow fever, A. aegypti breeds
in man-made habitats; and theoretically it should be
possible to eliminate or reduce vector populations. A
vaccine is available against yellow fever and is used
during emergencies.
A vaccine is not yet available against dengue/DHF,
and vector control remains the mainstay for pre-
vention and control. Source reduction and elimi-
nation, with the exception of Singapore, has not been
universally successful. Use of temephos (1 mg/1) or, in
some cases, methoprene as a larvicide to treat the
water containers has often been done with success.
During the outbreaks, application of ultra low vol-
ume (ULV) insecticides, such as malathion, feni-
trothion, from ground or air or using thermal fogs
(malathion or pirimiphos methyl in oil), have been
used with success. This, however, is not a long-term
solution of this problem.
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Fig. 2. Distribution of the lymphatic filariases and vector zones (WHO, 1984b).
Vectors of viruses causing encephalitis, such as
Japanese encephalitis, breed in such extensive areas
that larviciding is neither feasible nor cost-effective.
For outbreaks, malathion, fenitrothion, propoxur,
naled, chlorpyrifos, bioresmethrin, permethrin or del-
tamethrin have been employed as ULV applications,
either from ground or air.
For onchocerciasis vector control, the treatment of
choice is the larval control by aerial applications to
the river systems using temephos or, where resistance
in blackflies has developed, chlorphoxim or B.t. H-14
at weekly intervals. The largest vector control pro-
gramme in Africa and probably in the world, the On-
chocerciasis Control Programme in the Volta River
Basin area of West Africa involves weekly spraying
of almost 14,000 km of river.
Against tsetse, insecticidal sprays have employed
endosulfan, DDT, dieldrin and deltamethrin. Re-
cently, traps and screens impregnated with in-
secticides have been developed and found successful
against certain species of riverine tsetse.
American trypanosomiasis or Chagas' disease vec-
tors are largely controlled using residual insecticides
such as HCH and dieldrin. Resistance to dieldrin has
been recorded in a small area of Venezuela.
Dracunculiasis has been controlled by using tem-
ephos against cyclops species, improvement of the
design of wells to avoid contact of infected people
^ • \
,*r ••." A - -
S. haematobiui
S. japonicum
5. mekongi
Fig. 3a. Global distribution of schistosomiasis due to Schistosoma haemtobium, S. japonicum and
S. mekongi.
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S174275840002275X
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 17:05:21, subject to the Cambridge Core terms of use, available at
Vector-borne diseases of man 659
Fig. 3b. Global distribution of schistosomiasis due to Schistosoma mansoni and S. intercalatum (WHO,
1985).
Fig. 4. Distribution of onchocerciasis in Africa (WHO, 1987c).
Fig. 5. Distribution of sleeping sickness foci in Africa, T.b. gambiense areas of distribution to the left of
dotted line in West and Central Africa, T.b. rhodesiense to the right of line in Eastern and S. Africa
(WHO, 1987b).
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Fig. 6. Approximate distribution of Chagas' disease in the region of the Americas (WHO, 1985).
with water, and use of filters for drinking water. India
has embarked on the eradication of this disease using
the above strategy for control.
Other nuisance insects and vectors, such as syn-
anthropic flies, fleas, bedbugs, lice and cockroaches
are generally controlled using sanitary measures and
insecticides for example, for houseflies and cock-
roaches environmental sanitation. Proper garbage
disposal and use of screens, traps, and insecticides
have been used and recommended. Similar measures
are being applied to the control of bedbugs and lice.
A series of acaricides and insecticides are available
for the control of ticks and mites.
I have not commented much on the control of
nuisance causing species in the developed countries
but, since many of these are not involved in the
transmission of disease organisms, these have not the
same priority. Importance of these is, however, recog-
nized.
Socio-economic impact of vector-borne diseases
It is difficult to measure the socio-economic impact
of vector-borne diseases, because the actual cost of
illness, value of life, quality of life, and losses to the
family of the person when death occurs are impos-
sible to measure in a quantifiable term. "There are
those who die and that is sad enough, but there are
those who lead a hopeless life, the forgotten ones,
these women and men who are socially unable to
achieve self-realization and to be economically pro-
ductive" (Halfdan Mahler, Unpublished). Health
conditions affect the pace of development and the
developmental processes by an improved standard of
life ameliorate health. How then do we go about
measuring socio-economic impact of vector-borne
diseases? Economists have thus devised different ap-
proaches and among these the following deserve
mention:
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Fig. 7. The distribution of cutaneous and mucocutaneous leishmaniasis in the world (shaded
areas = endemic areas; dots = sporadic cases) (WHO, 1984).
Fig. 8. The distribution of visceral leishmaniasis in the world (shaded areas = endemic areas;
dots = sporadic cases) (WHO, 1984).
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Fig. 9. Areas in which dracunculiasis is reported or probably
exists (WHO, 1982).
(a) Cost effectiveness in terms of cost per person
protected, per case-year prevented, per death averted
and per healthy year gained. Of these, cost per case
year prevented and cost per healthy year gained are
the most useful concepts (Barlow and Grobar, 1986).
(b) Cost of the control programmes per unit of
population.
(c) Cost of alternative method, such as change of
the insecticide used.
(d) Morbidity and debility, work days lost and
effect on developmental activities, and
(e) Benefits of control.
Some aspects of socio-economic impact of malaria and
its control
Sinton (1935) wrote on what malaria costs India
and calculated the financial losses to the community
in terms of lost wages alone as Indian rupees 123 m
(100 m people suffered from malaria annually, of this
one-third were of the adult productive group, and
lost 15 days per year due to malaria). This sum would
be equivalent to $40 m then and a lot more now. This
type of analysis has several shortcomings and the
present day economists do not accept these findings
as very sound, because there are several flaws in this
analysis. Many of those who are sick are not em-
ployed in any case, but the cost of medical atten-
dance, loss to industry and other fields and ameliora-
tion of the situation after control can be noteworthy.
A good example of this is the gain in the agricultural
activity and production in the Terai area in the north
of India as well as Kunduz area in Afghanistan. This
area was dreaded by settlers prior to the introduction
of the control programme in the early fifties. Once
malaria was brought under control, there has been a
phenomenal agricultural growth in the area and what
was once malarious marshes has been transformed to
a prosperous green belt. No doubt agricultural tech-
nology development and other infrastructures played
a big role here, but it would not have been possible
if the area was still malarious. As Pampana (1963)
pointed out, the value of land that cannot be culti-
vated or developed due to malaria can only be
appreciated when it has been eradicated or con-
trolled.
Some argue that improved "health" will no doubt
increase production (both agricultural as well as
industrial), but because of the population growth
there will be more mouths to feed and, hence the
gains achieved by disease control will not be pro-
ductive economically. Again this argument is falla-
cious because social gains achieved by disease control
have to be looked at in a much broader sense and
developments generate employment and prod-
uctivity.
There has also been a debate whether control of
malaria with the reduction of deaths during in-
fancy and increasing of the expectation of life does
not bring about population explosion. It should be
pointed out that there are many other contributing
factors, such as improved health care, modern medi-
cines, etc. It has also been shown that the acceptance
of family welfare programmes is high when infant
mortality is no longer a looming danger. After all, the
rate of growth of population is least in highly devel-
oped societies where the infant mortality rates are
lowest and the expectation of life longest. Power,
irrigation, railway constructions, etc. can also suffer
when the mosquitogenic conditions of the sites
worsen and non-immune labour force is introduced
into the area. Harrison (1978) has recounted how the
control of malaria and yellow fever contributed to the
successful construction of the Panama Canal.
Prescott (Unpublished data) and Rosenfield et al.
(1980) analysed the economic consequences of dis-
eases and concluded that economic consequences,
including damages which can be quantified and losses
which cannot be easily valued can probably be better
measured in terms of benefits its control will generate.
Social impacts of vector-borne diseases have yet to be
carefully studied. The stresses resulting from chronic
non-infectious diseases have been analysed in terms
of resulting psychological disorders and behavioural
changes. This may also result in the reduced
ability to participate fully in family or community
life. Such effects are again difficult to measure
quantitatively.
Le Berre et al. (1977) considered that oncho-
cerciasis has the gravest socio-economic repercus-
sions in the Savannah countries of Africa where the
main issue is desertion of the villages. Economy of
these countries is essentially based on agriculture and
the utilization of these areas which are fertile, de-
pends on the situation vis-a-vis onchocerciasis.
Large-scale emigration from the infected areas makes
agricultural development difficult. Blindness, the ma-
jor complication of onchocerciasis, makes this disease
a major public health problem in W Africa for it
strikes mainly at economically active adults in the
prime of their life. This may directly cause substantial
excess mortality and indirectly stagnation or decline
in the human population. Eventually it leads to
abandonment of the villages. Blindness rates in some
villages may rise to 15% of the local population and
40% of the adult male workforce. Life expectancy of
the blind is shortened. Although blind persons may
not be idle and may be occupied in basket-making,
drawing water from wells, etc., they do become a
burden to the society. Onchocerciasis-infected vil-
lages are poor and this leads the younger population
to emigrate and thus the population becomes imbal-
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Table 2. Costs and benefits of controlling vector-borne diseases (costs of vector control)
Nature of cost Malaria Filariases Onchocerciasis African trypanosomiasis Schistosomiasis
Annual cost per
person protected
in 1984 ($)
Cost per case year
prevented
in 1984($)
Cost per death
averted ($)
Cost per healthy
year gained
1.57^}.85 (Indonesia)
6.64 (Liberia)
Drugs and insecticides Chemotherapy
0.59 (India)
Vector control
1.31 (Kenya)
12 (OCP area)
Vector control
1.88 (India)
Vector control
75.00 (Indonesia)
Vector control
233.15 (Nigeria)
Vector control and
Drugs 69.95 (Sri Lanka)
2.40 (Ivory Coast)
5.71 (Kenya)
Chemotherapy
11.79-51.96 (India)
20.00 (OCP area)
($) 239.61
0.44 (Sudan)
Drugs and vector control
2.23 (Tanzania)
Vector control only
16.91 (Brazil)
Vector control
2.52 (Iran)
Drugs and vector control
13.99-63.02 (St Lucia)
Table 3. Cost implications of insecticide resistance in malaria-vector control*
Country Base year
Latest
year Change in insecticide
Percentage increase of costs
(compared with 1959 costs)
Nicaragua
Sri Lanka
India
1959
DDT
1970-1975
DDT
1985
hypothetical
DDT only
1964
1973
1983
1978-1983
1985
Malathion, S0.40/house
Propoxur and malathion, $0.90/house
DDT, chlorphoxim and deltamethrin, $1.90/house
Malathion
BHC, malathion, DDT
82%
264%
764%
800%
64%
A. albimanus
A. culicifacies
A. culicifacies
•Adapted from Smith A. (1985, pers. commun.).
anced and the villages are occupied by old and blind
people.
Economic benefits of control of onchocerciasis
The beneficial changes are already noticeable in the
Onchocerciasis Control Project (OCP) in W Africa,
where available manpower has already increased and
improvements in productivity are apparent. New
land freed from disease is already being exploited.
Thus onchocerciasis control is considered to be a
cost-effective programme.
Cost of control
Noguer (1977) analysed the cost of vector-borne
disease control programmes with particular reference
to malaria. Due to fluctuations in the cost of in-
secticides from year to year and variations in the cost
of labour from country to country and frequent
changes in the insecticide used, whose costs vary
within very wide margins, it is not possible to give
precise figures which may be correct within space and
time. He estimated that in a zone of 1 m population
using DDT as the primary weapon, these costs would
have amounted to US $1.7 m (much more now). The
cost per capita of a programme of 8 years' duration
would be approximately US $8.00. Another way of
looking at it is the percentage of health budget which
is allocated to disease control. Cost of programmes
often represent a very important part of national
income. In 1974-1975, the Government of India
authorized 75% of the development budget for health
for malaria control activities. In Pakistan the 5-year
crash programme against malaria was more than
twice the total budget for health in 1975. In the Sudan
(Gezira Province), the estimated cost of an 8-year
malaria control programme (1976-1984) has been
estimated to be US$17 per capita. In Pakistan, a
5-year crash programme using mostly malathion
(because of widespread DDT-resistance) is $10 per
capita. The OCP programme in Volta River Basin
area was estimated to cost US $120 m for the period
1974-1993. The investment of control programme is
the equivalent of US$12 per capita. McCullough
(Unpublished) estimated that the cost of control
programmes (mollusciciding and chemotherapy) in
Tanzania in 1973 was approximately US$4.11 per
person at risk. Rosenfield et al. (1977) estimated that,
in Iran, chemotherapy cost only $2.46 per case year
prevented, as compared to $9.29 when mollusciciding
was used. This has been a trend of findings elsewhere
as well and the strategy of morbidity control for
schistosomiasis by use of drugs is now considered
more cost effective as compared to the schis-
tosomiasis control by use of molluscicides (WHO
1985b).
Costs and benefits of control
Barlow and Grobar (1986) have reviewed most
comprehensively the available literature on the costs
and benefits of controlling parasitic diseases. Table 2
gives some of the data presented. In view of the
importance of resource allocation for disease/vector
control, the economists feel that costs and benefits of
a control programme is a more balanced presentation
than costs alone.
Global pesticide requirements and costs for vector
control programmes in developing countries
Prices of insecticides vary greatly, being influenced
by many factors. Smith and Lossev (Unpublished)
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carried out an analysis based on a questionnaire sent
to 103 developing countries. On the basis of this
survey, the total cost of insecticides, solely for
national vector control programmes, would have
been no less than $100 m in 1984 and the figure would
be about $255 m when other expenses are added.
Most of our information in this respect comes from
the control of malaria vectors.
Except where resistance to DDT occurs in the
vectors, DDT accounts for a major part of the
expenditure on insecticides. Due to an acceptable
level of control achieved, DDT continues to be used
and is the mainstay of many antimalaria pro-
grammes. When DDT has to be replaced by other
insecticides, the cost increases profoundly. In global
terms, the direct and indirect effects of DDT-
resistance on malaria vectors were to promote a
considerable shift to other compounds or methods of
vector control. Table 3 gives some data showing the
increases due to replacement of DDT by other in-
secticides.
Thus insecticide resistance has been extremely
costly as far as malaria control is concerned and may
have cost several billion dollars over the last two
decades.
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